NEO — NEOGENOMICS INC
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1077183 ·
Last close
$16.41
Market Cap
$2.14B
52W High
$17.08
52W Low
$9.04
ADV30
2,587,629
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 201,656,000 | 91,878,000 | -9,771,000 | 2,238,000 | 1,352,243,000 | 145,539,000 | 566,511,000 |
| Mar 2026 | 186,672,000 | 80,864,000 | -18,241,000 | -17,106,000 | 1,346,531,000 | 146,143,000 | 517,771,000 |
| Dec 2025 | 190,170,000 | 83,343,000 | -12,788,000 | -9,881,000 | 1,359,830,000 | 159,618,000 | 523,268,000 |
| Sep 2025 | 187,797,000 | 80,446,000 | -19,928,000 | -27,129,000 | 1,374,780,000 | 164,117,000 | 536,490,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$22,049,000
Investing CF
$-19,901,000
Financing CF
$-11,386,000
CapEx
$-29,404,000
Dividends Paid
—
Buybacks
$-25,000,000
EPS Diluted TTM
$-0.40
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-448,674,000
Inventory
$27,137,000
Receivables
$175,405,000
ST Investments
$0
EBIT TTM
$-51,966,000
Pretax Income TTM
$-54,547,000
Interest Exp TTM
$2,581,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$766,294,976
EBITDA
$24,325,000
Free Cash Flow
$43,904,752
Enterprise Value
$2,411,110,912
Total Cash
$145,539,008
Total Debt
$448,368,000
Shares Out
130,211,780
Trailing EPS
$-0.38
Book Value
$6.14
ROE
-6.3%
ROA
-1.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 727,332,000 | -88,128,000 | -108,025,000 | 1,359,830,000 | 523,268,000 | — | 5,230,000 |
| Dec 2024 | 660,566,000 | -85,448,000 | -78,726,000 | 1,638,038,000 | 735,699,000 | — | 7,023,000 |
| Dec 2023 | 591,643,000 | -96,648,000 | -87,968,000 | 1,681,229,000 | 739,692,000 | — | -1,953,000 |
| Dec 2022 | 509,728,000 | -153,107,000 | -144,250,000 | 1,740,034,000 | 742,011,000 | — | -65,993,000 |
TTM Snapshot
Revenues TTM
$569,900,000
NetIncome TTM
$-102,777,000
OpCashFlow TTM
$0
Assets (Latest)
$1,638,038,000
Forward EPS
$0.34
Max Pain — expiry 2026-12-18
max pain strike: $10.00 · spot: $16.65 · call oi: 7,926 · put oi: 95Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GOF | GUGGENHEIM STRATEGIC OPPORTUNITIES FUND | $2.14B | $9.58 | — |
| CMPR | CIMPRESS plc | $2.13B | $87.52 | — |
| RUN | Sunrun Inc. | $2.15B | $8.92 | — |
| AEGXF | Aecon Group Inc. | $2.16B | $31.46 | — |
| NWN | Northwest Natural Holding Co | $2.11B | $50.22 | — |
News headlines (Yahoo Finance, 1h cache)
NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue?
2026-08-04 13:15 · Yahoo
NeoGenomics (NEO) Following Q2 Profit And Raised Outlook, Is Fair Value Already Priced In?
2026-08-04 02:07 · Yahoo
Why NeoGenomics (NEO) Stock Is Up Today
2026-07-30 09:09 · Yahoo
NeoGenomics Inc (NEO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ...
2026-07-29 05:02 · Yahoo
NeoGenomics Q2 Earnings Call Highlights
2026-07-28 22:04 · Yahoo
NeoGenomics’s (NASDAQ:NEO) Q2 CY2026: Beats On Revenue
2026-07-28 20:43 · Yahoo
Greenland Mines Sarfartoq Nd-Pr Rare Earth Project Valued Up to US$2.05 Billion With Pre-Tax IRR of 118.6% and Significant Additional Upside Potential
2026-08-25 04:01 · Yahoo
Neo Performance Materials (TSX:NEO) Dropped, So What Is Behind The Fresh Attention?
2026-08-25 02:08 · Yahoo
Neo Performance Materials (TSX:NEO) Stock Looks Fairly Priced After Record Q2 Results
2026-08-24 23:13 · Yahoo
NeoGenomics, Inc. (NEO) Hits Fresh High: Is There Still Room to Run?
2026-08-24 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.